# A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough

> **NCT03372603** · PHASE1,PHASE2 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 17 (actual)

## Conditions studied

- Cough

## Interventions

- **DRUG:** GSK2798745
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03372603
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-05
- **Primary completion:** 2018-10-08
- **Final completion:** 2018-10-08
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Study terminated due to lack of efficacy of GSK2798745 in chronic cough.
- **Last updated:** 2019-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03372603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03372603, "A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03372603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*